Trials / Recruiting
RecruitingNCT05761093
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
A Study to Evaluate Patient and Physician Benefit/ Risk Preferences for Treatment of Metastatic Prostate Cancer (mPC) in Hong Kong: a Discrete Choice Experiment
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 306 (estimated)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to examine the preference weightings in term of risk/ benefit attributes of treatment in physician and prostate cancer patients from different stages of disease.
Conditions
Timeline
- Start date
- 2022-09-07
- Primary completion
- 2025-12-31
- Completion
- 2026-03-31
- First posted
- 2023-03-09
- Last updated
- 2025-05-06
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT05761093. Inclusion in this directory is not an endorsement.